NIH, Columbia Team Employs Drug and Gene Screens to Find Antimalarial Candidates | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Using genome-wide association and linkage analyses combined with high-throughput growth inhibition assays, researchers from the National Institutes of Health and Columbia University have identified dozens of compounds that appear to thwart various strains of Plasmodium falciparum — along with genetic loci contributing to varying treatment response in the malaria-causing parasite.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.